These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38039314)

  • 21. Generation and characterization of a novel candidate gene therapy and vaccination vector based on human species D adenovirus type 56.
    Duffy MR; Alonso-Padilla J; John L; Chandra N; Khan S; Ballmann MZ; Lipiec A; Heemskerk E; Custers J; Arnberg N; Havenga M; Baker AH; Lemckert A
    J Gen Virol; 2018 Jan; 99(1):135-147. PubMed ID: 29154744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
    Dicks MD; Spencer AJ; Edwards NJ; Wadell G; Bojang K; Gilbert SC; Hill AV; Cottingham MG
    PLoS One; 2012; 7(7):e40385. PubMed ID: 22808149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy.
    Sayedahmed EE; Kumari R; Shukla S; Hassan AO; Mohammed SI; York IA; Gangappa S; Sambhara S; Mittal SK
    Vaccine; 2018 Oct; 36(45):6744-6751. PubMed ID: 30266488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein.
    Sumida SM; Truitt DM; Lemckert AA; Vogels R; Custers JH; Addo MM; Lockman S; Peter T; Peyerl FW; Kishko MG; Jackson SS; Gorgone DA; Lifton MA; Essex M; Walker BD; Goudsmit J; Havenga MJ; Barouch DH
    J Immunol; 2005 Jun; 174(11):7179-85. PubMed ID: 15905562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenovirus Specific Pre-Immunity Induced by Natural Route of Infection Does Not Impair Transduction by Adenoviral Vaccine Vectors in Mice.
    de Andrade Pereira B; Maduro Bouillet LE; Dorigo NA; Fraefel C; Bruna-Romero O
    PLoS One; 2015; 10(12):e0145260. PubMed ID: 26679149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroprevalence of neutralizing antibodies against human adenovirus type 55 in the South Korean military, 2018-2019.
    Park SY; Ko JH; Monoldorova S; Jeong J; Jeon BY; Kwon SH
    PLoS One; 2020; 15(7):e0236040. PubMed ID: 32673367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and Cross-Reactivity of Rhesus Adenoviral Vectors.
    Iampietro MJ; Larocca RA; Provine NM; Abbink P; Kang ZH; Bricault CA; Barouch DH
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of neutralizing antibodies against adenovirus type 14 and 55 in healthy adults in Southern China.
    Zheng X; Rong X; Feng Y; Sun X; Li L; Wang Q; Wang M; Liu W; Li C; Yang Y; Zhou R; Lu J; Feng L; Chen L
    Emerg Microbes Infect; 2017 Jun; 6(6):e43. PubMed ID: 28588291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults.
    Zhang S; Huang W; Zhou X; Zhao Q; Wang Q; Jia B
    J Med Virol; 2013 Jun; 85(6):1077-84. PubMed ID: 23588735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Sensitive and High-Throughput Flow Cytometry-Based Assay for Measuring Antibody Neutralization of Human Adenovirus Type 3.
    Liu Z; Tian X; Liu W; Xian Y; Chen W; Zhou R
    Virol Sin; 2021 Jun; 36(3):537-544. PubMed ID: 32990935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-Throughput Screening for the Prevalence of Neutralizing Antibodies against Human Adenovirus Serotype 5.
    Wettengel JM; Naka H; Dissen GA; Torgerson J; Pounder M; Mueller SF; Mueller E; Hagen P; Brandt M; Protzer U; Burwitz BJ
    Vaccines (Basel); 2024 Feb; 12(2):. PubMed ID: 38400138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trimeric knob protein specifically distinguishes neutralizing antibodies to different human adenovirus species: potential application for adenovirus seroepidemiology.
    Yu B; Dong J; Wang C; Wang Z; Gao L; Zhang H; Wu J; Kong W; Yu X
    J Gen Virol; 2014 Jul; 95(Pt 7):1564-1573. PubMed ID: 24764358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human adenovirus type 26 basic biology and its usage as vaccine vector.
    Majhen D
    Rev Med Virol; 2022 Nov; 32(6):e2338. PubMed ID: 35278248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mapping the epitope of neutralizing monoclonal antibodies against human adenovirus type 3.
    Tian X; Liu M; Su X; Jiang Z; Ma Q; Liao X; Li X; Zhou Z; Li C; Zhou R
    Virus Res; 2015 Oct; 208():66-72. PubMed ID: 26071383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of adenovirus neutralizing antigens using capsid chimeric viruses.
    Liu T; Fan Y; Li X; Gu S; Zhou Z; Xu D; Qiu S; Li C; Zhou R; Tian X
    Virus Res; 2018 Sep; 256():100-106. PubMed ID: 30096411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simian adenoviruses as vaccine vectors.
    Morris SJ; Sebastian S; Spencer AJ; Gilbert SC
    Future Virol; 2016 Sep; 11(9):649-659. PubMed ID: 29527232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epitope mapping and characterization of a neutralizing monoclonal antibody against human adenovirus type 3.
    Tian X; Li C; Xue C; Li X; Zhou Z; Zhou R
    Virus Res; 2013 Nov; 177(2):189-93. PubMed ID: 24018287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Worldwide increased prevalence of human adenovirus type 3 (HAdV-3) respiratory infections is well correlated with heterogeneous hypervariable regions (HVRs) of hexon.
    Haque E; Banik U; Monowar T; Anthony L; Adhikary AK
    PLoS One; 2018; 13(3):e0194516. PubMed ID: 29590206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence and molecular characterization of human respiratory syncytial virus and human adenovirus among children in Ado-Ekiti, Nigeria.
    Idris OO; Kolawole OM
    J Med Virol; 2022 Jun; 94(6):2548-2557. PubMed ID: 34816447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Murine Monoclonal Antibody With Potent Neutralization Ability Against Human Adenovirus 7.
    Wang R; Lu J; Zhou Q; Chen L; Huang Y; Yu Y; Yang Z
    Front Cell Infect Microbiol; 2019; 9():417. PubMed ID: 31867291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.